NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1770533788 MD
Verify on CMS → Robert Burr, MD
Endocrinology, Diabetes & Metabolism Physician in Cataumet, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 204 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
17%
generic claims · 78% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$403.14
20 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Robert Burr, MD filed 2,032 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in Cataumet, Massachusetts, prescribing 17% generic.
- 2K
- Part D claims, 2023
- 17%
- generic prescribing
- $403.14
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Robert Burr, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
2,032 Top 16% higher than 84% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Robert Burr, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Robert Burr, MD?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
2,032 23% vs specialty avg
Specialty distribution in Massachusetts
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Massachusetts providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Robert Burr, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 1400 RT 28A, Cataumet, MA, 02534, with a listed phone of (508) 374-9803. NPI 1770533788 was issued on 05/11/2006.
Medicare Part D records for calendar year 2023 show 2,032 prescription claims written by this provider, covering 204 Medicare beneficiaries and totaling roughly $1.7 million in drug spend, split 78% brand-name and 17% generic by claim count.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1770533788 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/11/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Robert Burr, MD. Source: openpaymentsdata.cms.gov.
Total received
$403
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Robert Burr, MD. To verify Robert Burr, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Robert Burr, MD - brand share 78.0%
Endocrinology, Diabetes & Metabolism Physician average
78% brand-name claims vs 17% generic, on 2,032 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
2,032
Total Claims
$1.7M
Total Drug Cost
204
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,084
- Total Day Supply
- 89,450
- Brand vs Generic
- 78% brand / 17% generic
- Brand Drug Cost
- $1.6M
- Generic Drug Cost
- $9K
Patient Demographics
- Average Patient Age
- 68.4 years
- Avg HCC Risk Score
- 1.50
- Gender Split
- 50% female / 50% male
- Age Distribution
- <65: 51, 65-74: 106, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Robert Burr, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Mounjaro
Mounjaro
303 claims
- Trulicity
Trulicity
279 claims
- Jardiance
Jardiance
263 claims
- Tresiba Flextouch … 96
Tresiba Flextouch U-200
96 claims
- Ozempic 95
Ozempic
95 claims
- Synjardy Xr 89
Synjardy Xr
89 claims
- Metformin Hcl Er 78
Metformin Hcl Er
78 claims
- Soliqua 100-33 78
Soliqua 100-33
78 claims
| Drug | Claims |
|---|---|
| Mounjaro Tirzepatide | 303 |
| Trulicity Dulaglutide | 279 |
| Jardiance Empagliflozin | 263 |
| Tresiba Flextouch U-200 Insulin Degludec | 96 |
| Ozempic Semaglutide | 95 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 89 |
| Metformin Hcl Er Metformin Hcl | 78 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 78 |
| Tresiba Flextouch U-100 Insulin Degludec | 48 |
| Levothyroxine Sodium | 47 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in MA →
All providers in Massachusetts →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Robert Burr, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Robert Burr, MD's 2,032 claims are below the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Burr.
Dr. Alice Abbott
MD
Leeds, MA
Dr. Adham Abdel Mottalib
MD
Boston, MA
Dr. Martin Abrahamson
M.D.
Boston, MA
Dr. Gail Adler
MD PHD
Boston, MA
Dr. Alexandra Albert
MD PHD
Worcester, MA
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Massachusetts medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Massachusetts
Frequently Asked Questions
What is Robert Burr, MD's specialty? ▼
Robert Burr, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Cataumet, Massachusetts. Credentials: MD.
How much does Robert Burr, MD prescribe under Medicare Part D? ▼
In 2023, Robert Burr, MD wrote 2,032 Medicare Part D claims totaling $1.7M in drug costs for 204 beneficiaries.
Where is Robert Burr, MD located? ▼
Robert Burr, MD is located at 1400 RT 28A, Cataumet, MA, 02534. Phone: (508) 374-9803.
What is Robert Burr, MD's NPI number? ▼
Robert Burr, MD's National Provider Identifier (NPI) is 1770533788, issued on 05/11/2006.
Does Robert Burr, MD prescribe more brand-name or generic drugs? ▼
Robert Burr, MD's prescribing is 78% brand-name and 17% generic drugs by claim count, with $1.6M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Robert Burr, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Robert Burr, MD's most frequently prescribed drugs include Mounjaro, Trulicity, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Robert Burr, MD accept Medicare? ▼
Robert Burr, MD appears in CMS Medicare data with 2,032 Part D claims and 204 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Robert Burr, MD's credentials? ▼
Robert Burr, MD's NPI is 1770533788 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.